EFIR yields 2000000.00% · JNJ yields 2.14%● Live data
📍 EFIR pulled ahead of the other in Year 1
Combined, EFIR + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EFIR + JNJ for your $10,000?
EGPI Firecreek, Inc., an independent oil and gas company, engages in the exploration, development, and exploitation of crude oil and natural gas properties primarily in the United States. The company focuses on the oil and gas projects located in the Permian Basin areas of Texas, and surrounding states and regions in the United States for activities related to oil and gas production, and related business and other opportunities. It holds 50% working interests and corresponding 32% net revenue interests in oil and gas leases and reserves located in Callahan, Stephens, and Shakelford counties in west central Texas; and 75% working interests in the J.B. Tubb Leasehold Estate/Amoco Crawar field located in the Ward County in Texas. The company also offers oilfield services for drill site preparation to clear and lay pipelines for operators; and services to maintain lease roads, set power poles, and clean up oilfield spills. In addition, it engages in the sale, design/build, integration, and installation of thermal solar systems for residential and commercial sites. The company was formerly known as Energy Producers Inc. and changed its name to EGPI Firecreek, Inc. in October 2004. The company is based in Paradise Valley, Arizona.
Full EFIR Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.